Respiporc Flu 3

Respiporc FLU3®: Active immunisation of pigs from the age of 56 days onwards including pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection.

NAME OF THE VETERINARY MEDICINAL PRODUCT 

Respiporc FLU3 suspension for injection for pigs 

QUALITATIVE AND QUANTITATIVE COMPOSITION 

Each dose of 2 ml contains: 

Active substances: 

Strains of inactivated Influenza A virus/swine/ 

Bakum/IDT1769/2003 (H3N2) ≥ 10.53 log2 GMNU1 

Haselünne/IDT2617/2003 (H1N1) ≥ 10.22 log2 GMNU1 

Bakum/1832/2000 (H1N2) ≥ 12.34 log2GMNU1 

1GMNU = Geometric mean of neutralizing units induced in Guinea pigs after twice immunisation with 0.5 ml of this vaccine 

Adjuvant: 

Carbomer 971 P NF 2.0 mg 

Excipient: 

Thiomersal 0.21 mg 

Indication for use, specifying the target species 

Active immunisation of pigs from the age of 56 days onwards including pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection. 

Onset of immunity: 7 days after primary vaccination. 

Duration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 

6 months in pigs vaccinated for the first time at 96 days and above.

Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity which provides clinical protection of piglets for at least 33 days after birth. 

Contraindications 

None. 

Use during pregnancy, lactation or lay 

Can be used during pregnancy and lactation. 

Interaction with other medicinal products and other forms of interaction 

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. 

Amounts to be administered and administration route 

For intramuscular use.

Piglets: 

Primary vaccination: 2 injections of one dose (2 ml) 

- From the age of 96 days, with an interval of 3 weeks between injections to achieve duration of immunity over 6 months. 

or 

- Between the age of 56 and 96 days, with an interval of 3 weeks between injections to achieve duration of immunity over 4 months. 

Gilts and sows: 

Primary vaccination: see above 

A booster is possible at each stage of pregnancy and lactation. When vaccination is performed 14 days prior to farrowing with one dose (2 ml), it provides maternally-derived immunity to the piglets which protects them from clinical signs of influenza at least until day 33 after birth. 

Maternally-derived immunity in the piglets interacts with antibody induction. Generally, maternally-derived antibodies induced by vaccination last for approx. 5-8 weeks after birth. In particular cases of multiple contacts of the sows with antigens (field infections + vaccination) the antibodies transmitted to the piglets may last until week 12 of life. In the latter case piglets should be vaccinated after the age of 96 days. 

Shelf-life 

Shelf life of the veterinary medicinal product as packaged for sale: 2 years. 

Shelf life after first opening the vial: 10 hours. 

Special precautions for storage 

Store in a refrigerator (2 ºC − 8 ºC). Do not freeze. 

Keep the vial in the outer carton in order to protect from light.

Back to top